ReviewDalton transactions (Cambridge, England : 2003)2022
Luminescent chromium(0) and manganese(I) complexes.
Review in Dalton transactions (Cambridge, England : 2003), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Organophosphides: A New Class of Luminophore Ligands for Copper(I) Carbene Based TADF Emitters and Photocatalysts.Angewandte Chemie (International ed. in English) · 2026Article
- Homomolecular Photon Upconversion in a Perylene-Decorated Iron(III) Complex.Journal of the American Chemical Society · 2025Article
- Structural Control of Metal-Centered Excited States in Cobalt(III) Complexes via Bite Angle and π-π Interactions.Journal of the American Chemical Society · 2025Article
- Xylylethynyl Titanocene with a Microsecond Emission Lifetime Photosensitizes Singlet-Oxygen Formation and Photon Upconversion.Inorganic chemistry · 2025Article
- Molecular Design Principles for Photoactive Transition Metal Complexes: A Guide for "Photo-Motivated" Chemists.Journal of the American Chemical Society · 2025Review
- Exploring the Photophysics and Photocatalytic Activity of Heteroleptic Rh(III) Transition-Metal Complexes Using High-Throughput Experimentation.Inorganic chemistry · 2024Article
- Controlling the Photophysical Properties of a Series of Isostructural dJournal of the American Chemical Society · 2024Article
- Tailoring the Photophysical Properties of a Homoleptic Iron(II) TetraInorganic chemistry · 2024Article
- Design Strategies for Luminescent Titanocenes: Improving the Photoluminescence and Photostability of Arylethynyltitanocenes.Inorganic chemistry · 2023Article
- Photoactive Metal-to-Ligand Charge Transfer Excited States in 3dJournal of the American Chemical Society · 2023Review
- Molecular Design Principles to Elongate the Metal-to-Ligand Charge Transfer Excited-State Lifetimes of Square-Planar Nickel(II) Complexes.Journal of the American Chemical Society · 2022Article
- Light-Driven Hydrodefluorination of Electron-Rich Aryl Fluorides by an Anionic Rhodium-Gallium Photoredox Catalyst.Angewandte Chemie (International ed. in English) · 2022Article
- Borylation in the Second Coordination Sphere of FeInorganic chemistry · 2022Article
- Manganese(I) Complex with Monodentate Arylisocyanide Ligands Shows Photodissociation Instead of Luminescence.Inorganic chemistry · 2022Article
- Cobalt(III) Carbene Complex with an Electronic Excited-State Structure Similar to Cyclometalated Iridium(III) Compounds.Journal of the American Chemical Society · 2022Article
- HeterolepticDalton transactions (Cambridge, England : 2003) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this Frontier article, recently discovered chromium(0) and manganese(I) complexes emitting from metal-to-ligand charge transfer (MLCT) excited states are highlighted. Chelating isocyanide ligands give access to this new class of 3d
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.